View in EDS

Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.

Saved in:
Bibliographic Details
Title: Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
Authors: Werner B; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Sjoquist KM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Espinoza D; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Yip S; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Chang G; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Cummins MM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia., Mileshkin L; Peter MacCallum Cancer Centre, Melbourne, Australia., Ananda S; Peter MacCallum Cancer Centre, Melbourne, Australia; Western Health, Furlong Road, St Albans, Australia; Epworth Freemasons Hospital, East Melbourne, Australia; Department of Medicine, Western Health, University of Melbourne, Melbourne, Australia., Shannon C; Mater Cancer Care Centre, South Brisbane, Australia., Friedlander M; Prince of Wales Hospital, Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Warton K; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Ford CE; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Electronic address: caroline.ford@unsw.edu.au.
Source: Translational oncology [Transl Oncol] 2024 May; Vol. 43, pp. 101914. Date of Electronic Publication: 2024 Feb 27.
Publication Type: Journal Article
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38417292
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Werner+B%22">Werner B</searchLink>; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Sjoquist+KM%22">Sjoquist KM</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Espinoza+D%22">Espinoza D</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Yip+S%22">Yip S</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Chang+G%22">Chang G</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Cummins+MM%22">Cummins MM</searchLink>; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Mileshkin+L%22">Mileshkin L</searchLink>; Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Ananda+S%22">Ananda S</searchLink>; Peter MacCallum Cancer Centre, Melbourne, Australia; Western Health, Furlong Road, St Albans, Australia; Epworth Freemasons Hospital, East Melbourne, Australia; Department of Medicine, Western Health, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Shannon+C%22">Shannon C</searchLink>; Mater Cancer Care Centre, South Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Friedlander+M%22">Friedlander M</searchLink>; Prince of Wales Hospital, Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Warton+K%22">Warton K</searchLink>; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Ford+CE%22">Ford CE</searchLink>; Gynaecological Cancer Research Group, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Electronic address: caroline.ford@unsw.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101472619%22">Translational oncology</searchLink> [Transl Oncol] 2024 May; Vol. 43, pp. 101914. <i>Date of Electronic Publication: </i>2024 Feb 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Neoplasia+Press%22">Neoplasia Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101472619 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1936-5233 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219365233%22">19365233 </searchLink><i>NLM ISO Abbreviation: </i>Transl Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38417292
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tranon.2024.101914
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101914
    Titles:
      – TitleFull: Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Werner B
      – PersonEntity:
          Name:
            NameFull: Sjoquist KM
      – PersonEntity:
          Name:
            NameFull: Espinoza D
      – PersonEntity:
          Name:
            NameFull: Yip S
      – PersonEntity:
          Name:
            NameFull: Chang G
      – PersonEntity:
          Name:
            NameFull: Cummins MM
      – PersonEntity:
          Name:
            NameFull: Mileshkin L
      – PersonEntity:
          Name:
            NameFull: Ananda S
      – PersonEntity:
          Name:
            NameFull: Shannon C
      – PersonEntity:
          Name:
            NameFull: Friedlander M
      – PersonEntity:
          Name:
            NameFull: Warton K
      – PersonEntity:
          Name:
            NameFull: Ford CE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1936-5233
          Numbering:
            – Type: volume
              Value: 43
          Titles:
            – TitleFull: Translational oncology
              Type: main
ResultId 1